First Metatarsophalangeal Joint Pathology

Also written as Hallux joint, First MTP, Podagra.

The first metatarsophalangeal (MTP) joint is the classic site for acute crystal arthropathies, especially gout, and for osteoarthritis in low‑resource settings. Recognising clinical patterns, using limited investigations and initiating appropriate therapy are essential for ward‑round competence.

Definition and diagnosis

Podagra is an acute mono‑articular inflammation of the first MTP joint, most often caused by monosodium urate crystal deposition. Diagnosis rests on clinical presentation and, when possible, joint aspiration showing negatively birefringent needle‑shaped crystals.

• Joint aspiration with polarized microscopy: Does the joint contain urate crystals? Positive finding confirms gout; absence suggests other causes.
• Serum uric acid: Is hyperuricaemia present? Elevated level supports gout but normal level does not exclude it.
• Plain radiograph of the foot: Are there erosions with overhanging edges? Suggests chronic gout; may also show osteoarthritis changes.

• Sudden onset of severe pain, swelling and erythema at the base of the big toe
• Warmth and limited range of motion
• History of hyperuricaemia, diuretic use, alcohol intake or rapid weight loss

Severity and staging

Acute gout attacks are staged as mild, moderate or severe based on pain intensity, joint involvement and systemic features. Chronic gout is staged by the presence of tophi, joint damage and renal involvement.

• Mild: pain tolerable, able to ambulate with support
• Moderate: pain limits walking, requires analgesia
• Severe: incapacitating pain, fever, systemic inflammation

Causes, most likely first

In low‑resource East African hospitals the most common causes of first MTP inflammation are:

• Urate crystal deposition (gout) – most frequent
• Calcium pyrophosphate deposition (pseudogout) – less common
• Septic arthritis – especially in diabetics or HIV patients
• Traumatic sprain or fracture of the hallux

How it presents

Patients describe a sudden, excruciating pain that peaks within hours, often after a heavy meal or alcohol binge. The joint becomes red, hot, swollen and the toe may appear deformed (flexed). Systemic fever is uncommon unless infection is present.

• Pain onset < 12 h
• Erythema and warmth over the joint
• Limited dorsiflexion of the hallux

Investigations

When microscopy is unavailable, combine bedside clues with basic labs to narrow the differential.

• Joint aspiration (if needle and microscope present): Confirms crystal type; guides definitive therapy.
• Full blood count: Leukocytosis suggests infection; normal count favours gout.
• C‑reactive protein or ESR: Markedly raised in septic arthritis; modest rise in gout.
• Serum uric acid: Elevated (> 7 mg/dL) supports gout; normal does not rule out.
• Foot X‑ray (if radiology available): Shows erosions, chondrocalcinosis or fracture.

• If joint aspiration is not possible, treat as gout if clinical picture fits and infection is unlikely.

Red flags and complications

Prompt recognition of infection or systemic spread prevents irreversible damage.

• Fever > 38 °C, chills, or rigors
• Rapidly expanding swelling with fluctuance
• Immunocompromise (HIV, diabetes, chronic steroid use)
• Renal impairment worsening hyperuricaemia

Management

Treat the acute inflammation first, then address the underlying metabolic disturbance.

• NSAID trial: Will pain improve within 24 h? Positive response supports gout; lack of response prompts reconsideration of infection.
• Colchicine loading dose: Rapid pain relief within 12 h indicates crystal arthritis; monitor for diarrhoea.

• NSAIDs (e.g., ibuprofen) – first‑line if no renal or GI contraindication
• Colchicine – useful when NSAIDs contraindicated; avoid in severe renal failure
• Corticosteroid injection into the joint or short oral course – for refractory cases or when infection is excluded
• Urate‑lowering therapy (allopurinol, febuxostat) – start after the acute attack resolves

Follow‑up and prevention

Educate patients on lifestyle and monitor uric acid levels to prevent recurrences.

• Limit purine‑rich foods, alcohol and fructose drinks
• Encourage hydration (> 2 L/day) and weight control
• Check serum uric acid 4–6 weeks after starting urate‑lowering therapy
• Screen for renal disease and hypertension

Often confused with

• Septic arthritis – distinguished by fever, high leukocytosis and purulent aspirate
• Pseudogout – calcium pyrophosphate crystals are positively birefringent and rhomboid
• Hallux valgus deformity – chronic deformity without acute inflammation

Where results can mislead

• Normal serum uric acid during an acute attack (up to 30 % of cases)
• Negative crystal analysis if fluid is scant or improperly examined

Questions an examiner may ask

• A 48‑year‑old farmer presents with 2‑day sudden severe pain in the right first MTP joint, no fever. What is your immediate management and why? — Give NSAID trial, consider colchicine if NSAID contraindicated; explain need to rule out infection before steroids.
• How would you differentiate acute gout from septic arthritis in a diabetic patient with a hot, swollen first MTP joint? — Discuss history, fever, leukocytosis, CRP, joint aspiration findings.
• Explain the pathophysiological reason why lower temperature in distal joints favours crystal deposition. — Describe reduced solubility of urate at cooler temperatures leading to supersaturation and nucleation.
• A patient with known chronic gout presents with a new first MTP swelling but normal serum uric acid. How do you interpret this? — Normal uric acid does not exclude gout; acute attacks can transiently lower levels; rely on clinical and crystal analysis.
• What are the contraindications to using NSAIDs in acute podagra in a low‑resource setting? — Renal insufficiency, active peptic ulcer, uncontrolled hypertension, heart failure.
• List three lifestyle measures that reduce recurrent gout attacks and explain the mechanism for each. — Reduce purine intake (less urate production), limit alcohol (decreases urate excretion), increase hydration (dilutes serum urate).
• When is surgical intervention indicated for first MTP pathology? — Chronic tophaceous gout causing deformity, joint destruction, or refractory infection requiring debridement.
• A patient on allopurinol develops an acute flare. What is the appropriate response? — Continue allopurinol, treat flare with NSAID/colchicine, educate that flares can occur during dose titration.

When to seek help

• Fever > 38 °C with joint swelling
• Rapidly worsening pain despite NSAIDs
• Signs of systemic sepsis (hypotension, tachycardia)
• New neurological deficits in the foot

Quick questions

Can gout be diagnosed without joint aspiration?

Yes, a classic clinical picture plus supporting labs can allow a presumptive diagnosis when aspiration is unavailable.

Why avoid colchicine in renal failure?

Colchicine is cleared renally; accumulation can cause severe toxicity, so dose reduction or alternative therapy is needed.

When should urate‑lowering therapy be started?

After the acute attack has settled, usually 2–4 weeks later, to avoid prolonging inflammation.